Needham & Company Remains Bullish on Medidata Solutions (MDSO) Despite Revenue Shortfall
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq hits intraday record high on Alphabet boost, Mideast negotiation hopes
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Medidata Reports Full-Year and Fourth Quarter 2015 Results
February 10, 2016 6:31 AM ESTRecord full-year revenue of $392.5 million, a 17% year-over-year increase Record full-year subscription revenue of $336.2 million, a 20% year-over-year increase Record full-year new client wins of 201, a 52% year-over-year increase Record full-year cash flow from operations of $87.0 million, a 41% year-over-year increase Provides 2016 revenue guidance of between $450 and $474 million
NEW YORK--(BUSINESS WIRE)--... More
Celgene Expands Relationship with Medidata in Enterprise Clinical Trial Technology
February 10, 2016 6:30 AM ESTGlobal Biopharma Adds Medidata Clinical Cloud® to Enhance Its Clinical Trial Data Management Capabilities
NEW YORK--(BUSINESS WIRE)-- Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that... More
